费城染色体易位中的人类c-abl原癌基因。 - Suppr

Suppr

超能文献

The human c-abl oncogene in the Philadelphia translocation.

作者信息

Groffen J, Stephenson J R, Heisterkamp N, Bartram C, de Klein A, Grosveld G

出版信息

J Cell Physiol Suppl. 1984;3:179-91. doi: 10.1002/jcp.1041210421.

DOI:10.1002/jcp.1041210421

PMID:6589229

Abstract

摘要

相似文献

The human c-abl oncogene in the Philadelphia translocation.费城染色体易位中的人类c-abl原癌基因。

J Cell Physiol Suppl. 1984;3:179-91. doi: 10.1002/jcp.1041210421.

bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia.慢性粒细胞白血病中bcr重排但c-abl未并列。

J Exp Med. 1985 Dec 1;162(6):2175-9. doi: 10.1084/jem.162.6.2175.

An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.慢性粒细胞白血病中的一种8千碱基abl RNA转录本。

Proc Natl Acad Sci U S A. 1984 Sep;81(18):5648-52. doi: 10.1073/pnas.81.18.5648.

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病中bcr和c-abl基因的独特融合

Cell. 1987 Oct 9;51(1):33-40. doi: 10.1016/0092-8674(87)90007-9.

The breakpoint of the Philadelphia chromosome 22 in chronic myeloid leukaemia is distal to the immunoglobulin lambda light chain constant region genes.慢性髓细胞白血病中费城染色体22的断点位于免疫球蛋白λ轻链恒定区基因的远端。

Mol Biol Med. 1983 Jul;1(1):11-9.

c-sis is translocated from chromosome 22 to chromosome 9 in chronic myelocytic leukemia.在慢性粒细胞白血病中，c-sis从22号染色体易位至9号染色体。

J Exp Med. 1983 Jul 1;158(1):9-15. doi: 10.1084/jem.158.1.9.

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.在慢性粒细胞白血病中，一种细胞癌基因易位至费城染色体。

Nature. 1982 Dec 23;300(5894):765-7. doi: 10.1038/300765a0.

The role of the Philadelphia translocation in chronic myelocytic leukemia.费城染色体易位在慢性粒细胞白血病中的作用。

Ann N Y Acad Sci. 1987;511:262-9. doi: 10.1111/j.1749-6632.1987.tb36254.x.

Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia.慢性粒细胞白血病中与易位断点相邻的c-ab1癌基因的定位。

Nature. 1983;306(5940):239-42. doi: 10.1038/306239a0.

Mapping of the c-sis oncogene on human chromosome 22 with respect to the breakpoint associated with chronic myeloid leukaemia.

Biosci Rep. 1983 Dec;3(12):1107-11. doi: 10.1007/BF01120203.

引用本文的文献

Improving the solubility and antileukemia activity of Wnt/β-catenin signaling inhibitors by disrupting molecular planarity.通过破坏分子的平面性来提高 Wnt/β-连环蛋白信号通路抑制剂的溶解度和抗白血病活性。

Bioorg Med Chem. 2022 Sep 1;69:116890. doi: 10.1016/j.bmc.2022.116890. Epub 2022 Jun 20.

Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia.克服对激酶抑制剂的耐药性：慢性髓性白血病的范例

Onco Targets Ther. 2022 Jan 25;15:103-116. doi: 10.2147/OTT.S289306. eCollection 2022.

Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia.BCR-ABL 酪氨酸激酶抑制剂在慢性髓性白血病中的作用谱。

Int J Hematol. 2021 May;113(5):632-641. doi: 10.1007/s12185-021-03126-6. Epub 2021 Mar 27.

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy.慢性髓性白血病：针对致癌酪氨酸激酶信号转导和克服耐药性以实现成功癌症治疗的范例。

Mol Cancer. 2018 Feb 19;17(1):49. doi: 10.1186/s12943-018-0780-6.

All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib.所有对酪氨酸激酶抑制剂耐药的慢性髓性细胞对波纳替尼高度敏感。

Oncotarget. 2012 Dec;3(12):1557-65. doi: 10.18632/oncotarget.692.

Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis.改良的螺旋-螺旋结构增强了与 Bcr-Abl 的相互作用并诱导细胞凋亡。

Mol Pharm. 2012 Jan 1;9(1):187-95. doi: 10.1021/mp200461s. Epub 2011 Dec 12.

Confirmation and refinement of the localisation of the c-MEL locus on chromosome 19 by physical and genetic mapping.

Hum Genet. 1989 Mar;81(4):382-4. doi: 10.1007/BF00283697.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验